Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
SGN-PDL1V for Cancer
Recruiting1 awardPhase 1
Cleveland, Ohio
This trial will test the safety of a new drug for solid tumors. It will also study side effects. The study has three parts and will enroll participants who have metastatic or unresectable solid tumors.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.